-+ 0.00%
-+ 0.00%
-+ 0.00%

Baird Maintains Neutral on HCA Healthcare, Raises Price Target to $423

Benzinga·08/14/2025 15:45:47
Listen to the news
Baird analyst Michael Ha maintains HCA Healthcare (NYSE:HCA) with a Neutral and raises the price target from $380 to $423.